Tag: M.W:100-200

1197-66-6, Name is 2,2,6,6-Tetramethyl-2H-3,5,6-trihydropyran-4-one, molecular formula is C9H16O2, belongs to Tetrahydropyrans compound, is a common compound. In a patnet, once mentioned the new application about 1197-66-6, SDS of cas: 1197-66-6

Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)

A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent 3-methoxy substituted analogue 27. Further SAR development around the THP ring resulted in an additional 10-fold increase in potency, exemplified by analogue 75 with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI50) values ranging from 0.3 to >100 muM. However, none of the cellular effects observed using ICMT inhibitors were as pronounced as those resulting from a farnesyltransferase inhibitor.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.SDS of cas: 1197-66-6. In my other articles, you can also check out more blogs about 1197-66-6

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Electric Literature of 5631-96-9, An article , which mentions 5631-96-9, molecular formula is C7H13ClO2. The compound – 2-(2-Chloroethoxy)tetrahydro-2H-pyran played an important role in people’s production and life.

Polytopic Cation Receptors. 2. Synthesis and Selective Complex Formation of Spiro-Linked “Multiloop Crown Compounds”

A new type of crown compound (1-10) featuring a spiro-linked assembly of two to four individual macrorings differing in ring size, rigidity, and donor characteristics is synthesized.Syntheses were achieved by means of high-dilution techniques and blocking/deblocking procedures beginning with pentaerythritol as the basic building block.The ability of the new ligands (“multiloop crown compounds”) to selectively form crystalline polyhomonuclear/heteronuclear complexes is studied.It is found that the symmetrically looped molecules (1a-c, 4a, 6, 7d) can incorporate two orthree identical metal cations well matched in their diameter (Li+, Na+, K+, Ca2+, Ba2+).Cations which are too large to fit into the crown rings of 1a-c complex in a sandwich-like manner; those which are too small effect a high hydration in their complexes.Asymmetrical 1d and 9 allow the common uptake of different metal ions, e.g., a combination of Li+ and Ba2+ or of 2K+ and Co2+.The specific occupation of the different subrings is discussed.Ligand 1b is shown to discriminate Ca2+ from Na+; 1c and 6 preferentially complex Ba2+ from a Ba2+/K+ mixture.Thus, the new ligands act as manifold selective cation receptors, corresponding to the specification of their binding compartments.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 5631-96-9, help many people in the next few years., Electric Literature of 5631-96-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Application of 2081-44-9, An article , which mentions 2081-44-9, molecular formula is C5H10O2. The compound – Tetrahydro-2H-pyran-4-ol played an important role in people’s production and life.

ALKYNYL-SUBSTITUTED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

The present invention relates to an alkynyl-substituted heterocyclic compound acting as an FGFR inhibitor, a preparation method therefor and a medical use thereof. In particular, the present invention relates to a compound as shown in general formula (I) and a pharmaceutically acceptable salt thereof; a pharmaceutical composition including the compound or a pharmaceutically acceptable salt thereof; a method for treating and/or preventing FGFR-associated diseases, particularly tumors, by using the compound or a pharmaceutically acceptable salt thereof; and a preparation method for the compound or a pharmaceutically acceptable salt thereof. The present invention also relates to the use of the compound or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition including the compound or a pharmaceutically acceptable salt thereof in the preparation of a drug for treating and/or preventing FGFR-associated diseases, particularly tumors, wherein the definition of each substituent group in general formula (I) is the same as that in the description.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 2081-44-9, help many people in the next few years., Application of 2081-44-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Electric Literature of 85064-61-5. Let¡¯s face it, organic chemistry can seem difficult to learn. Especially from a beginner¡¯s point of view. Like 85064-61-5, Name is Tetrahydropyranyl-4-acetic acid. In a document type is Patent, introducing its new discovery.

1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS

The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

If you are interested in 85064-61-5, you can contact me at any time and look forward to more communication.Electric Literature of 85064-61-5

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Application of 2081-44-9, Children learn through play, and they learn more than adults might expect. Science experiments are a great way to spark their curiosity, get their minds active, and encourage them to do something that doesn’t involve a screen. 2081-44-9, C5H10O2. A document type is Article, introducing its new discovery.

Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. the impact of physicochemical properties on ADME and PK

HIV-1 integrase is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recently, we reported the discovery of azaindole hydroxamic acids that were potent inhibitors of the HIV-1 IN enzyme. N-Methyl hydroxamic acids were stable against oxidative metabolism, however were cleared rapidly through phase 2 glucuronidation pathways. We were able to introduce polar groups at the beta-position of the azaindole core thereby altering physical properties by lowering calculated log D values (c Log D) which resulted in attenuated clearance rates in human hepatocytes. Pharmacokinetic data in dog for representative compounds demonstrated moderate oral bioavailability and reasonable half-lives. These ends were accomplished without a large negative impact on enzymatic and antiviral activity, thus suggesting opportunities to alter clearance parameters in future series.

If you are hungry for even more, make sure to check my other article about 2081-44-9. Application of 2081-44-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Application of 2081-44-9, Catalysts are substances that increase the reaction rate of a chemical reaction without being consumed in the process. 2081-44-9, Name is Tetrahydro-2H-pyran-4-ol, molecular formula is C5H10O2. In a Patent£¬once mentioned of 2081-44-9

SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS

The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, L, m, p and W are as defined in the specification.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 2081-44-9 is helpful to your research., Application of 2081-44-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

Reference of 19752-84-2, Catalysts are substances that increase the reaction rate of a chemical reaction without being consumed in the process. 19752-84-2, Name is Tetrahydro-2H-pyran-3-ol, molecular formula is C5H10O2. In a Patent£¬once mentioned of 19752-84-2

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 19752-84-2 is helpful to your research., Reference of 19752-84-2

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.5631-96-9, Name is 2-(2-Chloroethoxy)tetrahydro-2H-pyran, molecular formula is C7H13ClO2. In a Article£¬once mentioned of 5631-96-9, Computed Properties of C7H13ClO2

Synthesis and cation complexation properties of new macrolides

The cis-2-alkyl-3-oxy-tetrahydropyran unit as a novel structure for the design and synthesis of a new type of ionophores with C2-symmetry is reported. The synthesis of seven different macrolides and a crown ether and their cation complexation properties were investigated. The X-ray crystal structure of some of the receptors provides valuable information on the preferred conformation of tetrahydropyrans in the solid state that can be related to the cation complexation properties in solution. The kinetic template effect has been proved to be a useful tool to improve the yield and selectivity in the synthesis of macrodiolide 3.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Computed Properties of C7H13ClO2, you can also check out more blogs about5631-96-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 2081-44-9, Name is Tetrahydro-2H-pyran-4-ol, molecular formula is C5H10O2. In a Patent£¬once mentioned of 2081-44-9, COA of Formula: C5H10O2

Imidazobenzodiazepines

There are described novel pharmaceutically active substances which have a pronounced affinity to the central benzodiazepine receptors and which have only a low toxicity.These active substances, namely imidazobenzodiazepines of the formula STR1 wherein A is lower alkylene, n is zero or 1, R 1 is lower alkynyl, lower alkenyl, aryl, (C 3-8)-cycloalkyl optionally substituted by lower alkyl or (C 5-8)-cycloalkenyl optionally substituted by lower alkyl, or a 5- or 6-membered saturated or unsaturated heterocycle which contains an oxygen or sulphur atom as a ring member and which is optionally substituted by lower alkyl, R 4 and R 5 each are hydrogen, halogen, trifluoromethyl, cyano, nitro, amino or lower alkyl and either R 2 is hydrogen and R 3 is lower alkyl or R 2 and R 3 together are dimethylene, trimethylene or propenylene, the compounds of formula I in which R 2 and R 3 together are dimethylene, trimethylene or propenylene having the (S) or (R,S) configuration with reference to the carbon atom denoted by gamma,and their pharmaceutically acceptable acid addition salts, can be used as medicaments in the form of pharmaceutical preparations, especially in the control of convulsions and anxiety states and/or in the partial or complete antagonization of some or all activities which 1,4-benzodiazepines having tranquillizing activity or other substances display via the central benzodiazepine receptors.

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data.COA of Formula: C5H10O2, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 2081-44-9, in my other articles.

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics

A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 2081-44-9, Name is Tetrahydro-2H-pyran-4-ol, molecular formula is C5H10O2. In a Patent£¬once mentioned of 2081-44-9, Safety of Tetrahydro-2H-pyran-4-ol

NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME

The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Safety of Tetrahydro-2H-pyran-4-ol. In my other articles, you can also check out more blogs about 2081-44-9

Reference£º
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics